| Français | ISMP (US) | Feedback |
 |
Webinar |
 |
Earlier this year, ISMP Canada undertook a survey to better understand the extent of healthcare professionals’ knowledge deficits or gaps that could contribute to medication incidents with HYDROmorphone. This one hour interactive webinar is designed to share the key findings of the HYDROmorphone Knowledge Assessment survey.
Learning Objectives:
At the conclusion of this webinar, participants will be able to:
- describe the key findings of the HYDROmorphone knowledge assessment survey
- recognize some of the factors that make use of HYDROmorphone error-prone
- understand the purpose of the upcoming ISMP Canada HYDROmorphone demonstration project and how individual practice sites can participate
| Audience: | Hospital administrators, medication safety and quality officers, and healthcare practitioners (e.g., physicians, nurses, pharmacists, and pharmacy technicians) interested in medication safety.
|
| Date: | Thursday, September 13, 2012 |
| Time: |
9:00 am – 10:00 am PDT 10:00 am – 11:00 am MDT 11:00 am – 12:00 pm CDT 12:00 pm – 1:00 pm EDT 1:00 pm – 2:00 pm ADT 1:30 pm – 2:30 pm NDT Time zone map |
| Duration: | 1 hour |
| Cost: | This is a complimentary ISMP Canada webinar sponsored through a grant from Health Canada |
| Presenter: |
Julie Greenall, RPh, BScPhm, MHSc, FISMPC, Interim Operations Leader, ISMP Canada
|
| Moderator: |
Lynn Riley, RN, Educator & Medication Safety Specialist, ISMP Canada
|
Contact Us: webinars@ismp-canada.org
Speaker
|
Julie Greenall, RPh, BScPhm, MHSc, FISMPC, Interim Operations Leader, ISMP Canada Julie Greenall joined ISMP Canada in 2004 to complete the first Canadian Fellowship in Safe Medication Management and is now Interim Operations Leader. Her responsibilities include medication system safety reviews and critical incident analysis. |
Background
It was determined that an assessment of physicians’, nurses’, and pharmacists’ knowledge related to the use and administration of HYDROmorphone was needed to identify potential knowledge gaps. Furthermore, it was felt that the types and magnitude of any gaps identified would assist in planning future interventions to decrease the potential for harm with this medication. The survey questions covered the pharmacologic properties of HYDROmorphone, indications for use, adverse effects, usual dosage, dosing calculations, and difference in potency between HYDROmorphone and morphine.
The response to the survey was tremendous, with a total of 4399 respondents completing all or part of the survey, and 3476 respondents completing the knowledge assessment questions. Responses were received from every province and territory and represented healthcare disciplines involved in the prescribing, dispensing, preparation, administration, and/or monitoring of HYDROmorphone.
Related Links:
ISMP Canada Safety Bulletins:
Report: Survey:Contact Information
Mail: |
4711 Yonge Street, Suite 501 Toronto, ON M2N 6K8 |
Email: |
webinars@ismp-canada.org |
Phone: |
416-733-3131 ext. 236 |
Toll Free: |
1-866-544-7672 ext. 236 |
Fax: |
416-733-1146 |
